WAM
AEGR

Wolverine Asset Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Wolverine Asset Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,400
Closed -$30K – 1443
2016
Q3 		$30K Hold
10,400
– – ﹤0.01% 1104
2016
Q2 		$15K Buy
10,400
+10,296
+9,900% +$23.6K ﹤0.01% 1118
2016
Q1 		$178K Sell
104
-1,260
-92% -$7.8K 0.01% 687
2015
Q4 		$1.69M Buy
1,364
+89
+7% +$1.07K 0.04% 384
2015
Q3 		$1.26M Sell
1,275
-1,049
-45% -$18.7K 0.03% 443
2015
Q2 		$1.06M Buy
2,324
+1,854
+394% +$40.1K 0.02% 454
2015
Q1 		$364K Sell
470
-1,254
-73% -$31.9K 0.01% 709
2014
Q4 		$1.23M Buy
1,724
+703
+69% +$17.7K 0.02% 402
2014
Q3 		$267K Buy
+1,021
New +$31.7K 0.01% 927

Wolverine Asset Management's AEGR Position: Q4 2016 in Review

Wolverine Asset Management sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 13,354 shares — an estimated $39K sold.

Wolverine Asset Management first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $39K in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Wolverine Asset Management reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Wolverine Asset Management sold 13,354 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $39K.
  • Wolverine Asset Management first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Wolverine Asset Management's Aegerion Pharmaceuticals position peaked at $39K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Wolverine Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.